Rosemarie Schmandt

7.5k citations

65 papers · 4.6k indexed · 2 hit papers · h-index 32

Co-authors: Karen H. Lu Anil K. Sood Michaela Onstad Charles N. Landen Gabriel Lopez‐Berestein Michael T. Deavers Arturo Chávez‐Reyes Corazon D. Bucana
Topics: Endometrial and Cervical Cancer Treatments (11 papers)Cancer, Lipids, and Metabolism (9 papers)Metabolism, Diabetes, and Cancer (8 papers)
Cited by: Cancer Research Reproductive Medicine Obstetrics and Gynecology
Journals: Journal of Biological Chemistry Nature Communications Journal of Clinical Oncology
Partner nations: United States Canada Japan

In The Last Decade

Rosemarie Schmandt

65 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

2016 622 citations Tsz-Lun Yeung, Suet‐Ying Kwan et al. Nature Communications profile →
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment

2016 400 citations Michaela Onstad, Rosemarie Schmandt et al. profile →

Peers

Countries citing papers authored by Rosemarie Schmandt

Since Specialization

Citations

This map shows the geographic impact of Rosemarie Schmandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemarie Schmandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemarie Schmandt more than expected).

Fields of papers citing papers by Rosemarie Schmandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemarie Schmandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemarie Schmandt. The network helps show where Rosemarie Schmandt may publish in the future.

Co-authorship network of co-authors of Rosemarie Schmandt

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemarie Schmandt. A scholar is included among the top collaborators of Rosemarie Schmandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemarie Schmandt. Rosemarie Schmandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching 2022 ·Journal of Alzheimer s Disease ·(unknown),(unknown),Omar Hasan,Xiaoqian Jiang,Yejin Kim,(unknown),Rosemarie Schmandt,(unknown),(unknown),(unknown),Qian Xiao,Paul E. Schulz	60
2	Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications 2021 ·Journal of Controlled Release ·Brenda Melendez,Sarita R. Shah,Yunyun Jiang,Joseph Dottino,Emma Watson,Hannah A. Pearce,(unknown),Rosemarie Schmandt,Qian Zhang,(unknown),Joseph Celestino,Bryan Fellman,Ying Yuan,Karen H. Lu,Antonios G. Mikos,Melinda S. Yates	5
3	ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment 2020 ·Nature Communications ·(unknown),Tsz-Lun Yeung,Abhinav Achreja,Hongyun Zhao,Kay‐Pong Yip,Suet‐Ying Kwan,Michaela Onstad,Jianting Sheng,Ying Zhu,Dodge L. Baluya,(unknown),Ángela Rynne‐Vidal,Rosemarie Schmandt,Matthew L. Anderson,Karen H. Lu,Stephen T.C. Wong,Deepak Nagrath,Samuel C. Mok	39
4	Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression 2020 ·Cancers ·Suet‐Ying Kwan,(unknown),Tsz-Lun Yeung,Ángela Rynne‐Vidal,Kwong‐Kwok Wong,John I. Risinger,Hui‐Kuan Lin,Rosemarie Schmandt,Melinda S. Yates,Samuel C. Mok,Karen H. Lu	27
5	The Search Continues 2014 ·International Journal of Gynecological Cancer ·Larissa A. Meyer,Brian M. Slomovitz,Bojana Djordjevic,Shannon N. Westin,David A. Iglesias,Mark F. Munsell,Yunyun Jiang,Rosemarie Schmandt,Russell R. Broaddus,Robert L. Coleman,John Galbincea,Karen H. Lu	17
6	Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy 2013 ·Molecular Cancer Therapeutics ·David A. Iglesias,Melinda S. Yates,Dharini van der Hoeven,Travis L. Rodkey,Qian Zhang,Ngai Na Co,Jennifer K. Burzawa,Sravanthi Chigurupati,Joseph Celestino,Jessica L. Bowser,Russell R. Broaddus,John F. Hancock,Rosemarie Schmandt,Karen H. Lu	64
7	Chemopreventive effects of metformin on obesity-associated endometrial proliferation 2013 ·American Journal of Obstetrics and Gynecology ·Qian Zhang,Joseph Celestino,Rosemarie Schmandt,Adrienne S. McCampbell,Diana L. Urbauer,Larissa A. Meyer,Jennifer K. Burzawa,Marilyn Huang,Melinda S. Yates,David A. Iglesias,Russell R. Broaddus,Karen H. Lu	42
8	Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors 2011 ·Clinical Cancer Research ·Ann H. Klopp,Yan Zhang,Travis Solley,Felipe Amaya‐Manzanares,Frank C. Marini,Michael Andreeff,Bisrat G. Debeb,Wendy A. Woodward,Rosemarie Schmandt,Russell R. Broaddus,Karen W. Lu,Mikhail G. Kolonin	143
9	Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models 2010 ·Cancer Biology & Therapy ·Chunhua Lu,Mian M.K. Shahzad,Myrthala Moreno‐Smith,Yvonne G. Lin,Nicholas B. Jennings,Julie K. Allen,Charles N. Landen,Lingegowda S. Mangala,Guillermo N. Armaiz-Peña,Rosemarie Schmandt,Alpa M. Nick,Rebecca L. Stone,Robert B. Jaffe,Robert L. Coleman,Anil K. Sood	66
10	Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma 2007 ·Cancer Research ·Chunhua Lü,Tomás Bonome,Yang Li,Aparna A. Kamat,Liz Y. Han,Rosemarie Schmandt,Robert L. Coleman,David M. Gershenson,Robert B. Jaffe,Michael J. Birrer,Anil K. Sood	149
11	Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions 2006 ·Oncogene ·Meera Nanjundan,(unknown),Rosemarie Schmandt,Karen Smith‐McCune,Gordon B. Mills	11
12	The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary 2006 ·Cancer Biology & Therapy ·Rosemarie Schmandt,Marsha Bennett,(unknown),Angela Thornton,Feng Jiang,Russell R. Broaddus,Charlotte C. Sun,Karen H. Lu,Anil K. Sood,David M. Gershenson	62
13	Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer 2006 ·JNCI Journal of the National Cancer Institute ·Charles N. Landen,Chunhua Lu,Liz Y. Han,Karen Coffman,Elizabeth Bruckheimer,Jyotsnabaran Halder,Lingegowda S. Mangala,William M. Merritt,Yvonne G. Lin,(unknown),Rosemarie Schmandt,Aparna A. Kamat,Yang Li,Premal H. Thaker,David M. Gershenson,Nila U. Parikh,Gary E. Gallick,Michael S. Kinch,Anil K. Sood	99
14	Expression of imatinib mesylate-targeted kinases in endometrial carcinoma 2004 ·Gynecologic Oncology ·Brian M. Slomovitz,Russell R. Broaddus,Rosemarie Schmandt,Weiguo Wu,Jonathan C. Oh,Lois M. Ramondetta,Thomas W. Burke,David M. Gershenson,Karen H. Lu	26
15	Expression of c‐ABL, c‐KIT, and platelet‐derived growth factor receptor‐β in ovarian serous carcinoma and normal ovarian surface epithelium 2003 ·Cancer ·Rosemarie Schmandt,Russell R. Broaddus,Karen H. Lu,Hyun S. Shvartsman,Angela Thornton,Anaís Malpica,Charlotte C. Sun,Diane C. Bodurka,David M. Gershenson	85
16	Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma 2003 ·Molecular Carcinogenesis ·Amir A. Jazaeri,Karen H. Lu,Rosemarie Schmandt,Charles P. Harris,Pulivarthi H. Rao,Christos Sotiriou,Gadisetti V.R. Chandramouli,David M. Gershenson,Edison T. Liu	68
17	A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets 2003 ·Gynecologic Oncology ·Lois M. Ramondetta,Thomas W. Burke,Anuja Jhingran,Rosemarie Schmandt,Michael W. Bevers,Judith K. Wolf,Charles F. Levenback,Russell R. Broaddus	31
18	Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells 1999 ·Oncogene ·Rosemarie Schmandt,Stanley K. Liu,(unknown)	59
19	Mammalian NUMB is an evolutionarily conserved signaling adapter protein that specifies cell fate 1996 ·Current Biology ·Joseph M. Verdi,Rosemarie Schmandt,Arash Bashirullah,Sara Jacob,(unknown),Constance G. Craig,(unknown),Howard D. Lipshitz,C. Jane McGlade	139
20	Transmembrane signaling by the interleukin-2 receptor: progress and conundrums 1993 ·Seminars in Immunology ·Gordon B. Mills,Rosemarie Schmandt,Spencer B. Gibson,Bernadine Leung,Mary Hill,Chris May,Yufang Shi,Donald R. Branch,Laszlo Radvanyi,Kenneth E. Truitt,John B. Imboden	28

About Rosemarie Schmandt

Rosemarie Schmandt is a scholar working on Obstetrics and Gynecology, Cancer Research and Immunology and Allergy, having authored 65 papers that have together received 4.6k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (11 papers), Cancer, Lipids, and Metabolism (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Reproductive Medicine (735 citations) and Obstetrics and Gynecology (566 citations). Rosemarie Schmandt has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Karen H. Lu, Anil K. Sood, Michaela Onstad, Charles N. Landen, Gabriel Lopez‐Berestein, Michael T. Deavers, Arturo Chávez‐Reyes, Corazon D. Bucana, Gordon B. Mills and David A. Iglesias. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact